Related Experiment Video
Updated: Jun 12, 2025

11:56
Fluorescence Imaging with One-nanometer Accuracy FIONA
Published on: September 26, 2014
17.6K
J-Aggregated Fluorescence Nanoparticles with Multichromatic Performance Enable Sensitive LFIA Platform
Gan Zhang1, Keyang Lai1, Lilin Zhang2
1State Key Laboratory of Food Science and Resources, Nanchang University, 330047 Nanchang, China.
Nano Letters
|April 18, 2025
Summary
We developed J-aggregated fluorescence nanoparticles (JNPs) for sensitive, simultaneous detection of T-2 and AFB1 toxins using a multiplexed lateral flow immunoassay (LFIA). This biosensing approach significantly enhances detection limits compared to conventional methods.
Area of Science:
- Nanotechnology
- Biosensing
- Analytical Chemistry
Background:
- Conventional lateral flow immunoassays (LFIA) suffer from limited sensitivity and single signal output.
- Development of sensitive and multiplexed detection platforms is crucial for rapid on-site toxin analysis.
Purpose of the Study:
- To develop J-aggregated fluorescence nanoparticles (JNPs) as multichromatic reporters for enhanced LFIA.
- To achieve simultaneous and sensitive detection of T-2 and AFB1 toxins on a multiplexed LFIA platform.
Main Methods:
- Synthesized JNPs exhibiting a strong J-aggregation phenomenon with red-shifted emission (∼620 nm).
- Developed a multiplexed LFIA platform (JNPs-LFIA) using green and red emitting JNPs.
- Quantitatively detected T-2 and AFB1 toxins on the developed JNPs-LFIA platform.
Main Results:
- JNPs displayed red-shifted emission due to nanoparticle confinement and J-aggregation.
- JNPs-LFIA achieved limits of detection of 0.645 ng mL⁻¹ for T-2 toxin and 0.0035 ng mL⁻¹ for AFB1 toxin.
- The developed JNPs-LFIA showed 3.5-fold and 12.2-fold higher sensitivity than AuNPs-LFIA for T-2 and AFB1 toxins, respectively.
Conclusions:
- This work presents an efficient strategy for designing multichromatic immunoprobes.
- The developed JNPs-LFIA platform offers a sensitive and simultaneous detection method for T-2 and AFB1 toxins.
- This advancement promotes the development of novel reporters for advanced biosensing applications.

